By Ahmed El-Medany Treatment with a ‘quadpill’ containing quarter doses of four antihypertensive drugs demonstrated better blood pressure control than initial monotherapy with full-dose irbesartan,…
View More Polypill beats monotherapy for hypertension: results from the QUARTET studTag: Clinical Trials
Highlights from Day 2 of the ESC 2021 congress – MASTER DAPT
Presented by Dr. Marco Valgimigli, the MASTER DAPT trial assessed whether 1 month of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), with a…
View More Highlights from Day 2 of the ESC 2021 congress – MASTER DAPTHighlights from Day 1 of the ESC congress – SMART-MI
By Ahmed El-Medany As usual, there were a multitude of fascinating trials presented at the Hot Line session at the ESC Congress 2021. Professor Axel…
View More Highlights from Day 1 of the ESC congress – SMART-MICurrent use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44,000 patients
Dr Amit Bhan examines a study on Novel Oral Anticoagulants recently published in the European Heart Journal.
View More Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44,000 patientsESC Congress 2020 – The Digital Experience
Dr Nadir Elamin, Cardiology SpR, reports on the third day of the European Society of Cardiology Congress, taking place entirely online this year due to the banning of public gatherings in the Netherlands to prevent the spread of COVID-19
View More ESC Congress 2020 – The Digital Experience